ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 17, 2024
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-05-15$430.93/sh−54$23,270→ 25,813 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 5/10/2023.